Why Pfizer is special

Drug stocks operate under distinct negatives. For example, new drugs take years to win regulatory approval, if ever. As well, they face increasing litigation and aggressive competition from generics.

However, we feel Pfizer will continue to overcome these challenges. Its high research spending is letting… Read More